Deutsche Bank Starts Visa (V) at Buy; Implementing A New Strategy in A Post-Durbin World
Get Alerts V Hot Sheet
Price: $371.04 +1.45%
Rating Summary:
45 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
45 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Deutsche Bank initiates coverage on Visa (NYSE: V) with a Buy. PT $107.00.
Deutsche analyst says, "With the final rules of Durbin on the table, we believe Visa is implementing a growth strategy to capitalize on the new regulation and benefit from the secular shift to electronic payments. Resulting from the Durbin Amendment, we believe too much noise is made over the potential loss of Visa’s PIN debit revenue, which in our worst case scenario would only cause a 1-2% hit to top-line results (well within FY12 guidance). As Visa’s strategy becomes better understood, we expect Visa’s multiple to continue to expand."
For more ratings news on Visa click here and for the rating history of Visa click here.
Shares of Visa closed at $84.99 yesterday.
Deutsche analyst says, "With the final rules of Durbin on the table, we believe Visa is implementing a growth strategy to capitalize on the new regulation and benefit from the secular shift to electronic payments. Resulting from the Durbin Amendment, we believe too much noise is made over the potential loss of Visa’s PIN debit revenue, which in our worst case scenario would only cause a 1-2% hit to top-line results (well within FY12 guidance). As Visa’s strategy becomes better understood, we expect Visa’s multiple to continue to expand."
For more ratings news on Visa click here and for the rating history of Visa click here.
Shares of Visa closed at $84.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
- TD Cowen Assumes Crescent Biopharma Inc (CBIO) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share